A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis (Q48081174)

8 February 2018

title

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis (English)

1 reference

8 February 2018

1 reference

Matt van de Rijn

1 reference

8 February 2018

Jonathan R. Pollack

object named as

Jonathan R Pollack

1 reference

8 February 2018

author name string

Jacques Lapointe

1 reference

8 February 2018

Young H Kim

1 reference

8 February 2018

Melinda A Miller

1 reference

8 February 2018

Chunde Li

1 reference

8 February 2018

Gulsah Kaygusuz

1 reference

8 February 2018

David G Huntsman

1 reference

8 February 2018

James D Brooks

1 reference

8 February 2018

publication date

2 March 2007

1 reference

8 February 2018

published in

Modern Pathology

1 reference

8 February 2018

volume

1 reference

8 February 2018

issue

1 reference

8 February 2018

page(s)

467-473

1 reference

8 February 2018

Update on hormone-refractory prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Cloning and characterization of the cDNA and gene for human epitheliasin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

7 January 2021

inferred from DOI database lookup

Management of patients with an increasing prostate-specific antigen after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

7 January 2021

inferred from DOI database lookup

ETS transcription factors and their emerging roles in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800759

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/MODPATHOL.3800759

1 reference

8 February 2018

release_obywj5vzwfdnrfs2t35fk7d5xe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/obywj5vzwfdnrfs2t35fk7d5xe

24 November 2022

mapped directly with Wikidata item

1 reference

8 February 2018